Brain Tumor Segmentation, and Cross-Modality Domain Adaptation for Medical Image Segmentation

Ujjwal Baid

ISBN 10: 3031761626 / ISBN 13: 9783031761621

Published by Springer Nature Switzerland, Springer Nature Switzerland Dez 2024, 2024

About this Item

Neuware -This book constitutes the refereed proceedings of the Brain Tumor Segmentation Challenge, BraTS 2023, as well as the Cross-Modality Domain Adaptation Challenge, CrossMoDA 2023. These events were held in conjunction with the Medical Image Computing for Computer Assisted Intervention Conference, MICCAI 2023, during October 8-12, 2023.The 37 full papers presented in this volume were selected form 23 submissions. They describe the research of computational scientists and clinical researchers working on brain lesions, and specifically glioma, multiple sclerosis, cerebral stroke, traumatic brain injuries, vestibular schwannoma, and white matter hyper-intensities of presumed vascular origin.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 412 pp. Englisch.

Seller Inventory # 9783031761621

Bibliographic Details

• Title: Brain Tumor Segmentation, and Cross-Modality Domain Adaptation for Medical Image Segmentation
• Publisher: Springer Nature Switzerland, Springer Nature Switzerland Dez 2024
• Publication Date: 2024
• Language: English
• ISBN 10: 3031761626
• ISBN 13: 9783031761621
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 235W x 155H x 23D millimeters 235 millimeters width by 155 millimeters height by 23 millimeters depth
• Weight: 622 grams

About this title

Synopsis

This book constitutes the refereed proceedings of the Brain Tumor Segmentation Challenge, BraTS 2023, as well as the Cross-Modality Domain Adaptation Challenge, CrossMoDA 2023. These events were held in conjunction with the Medical Image Computing for Computer Assisted Intervention Conference, MICCAI 2023, during October 8-12, 2023.

The 37 full papers presented in this volume were selected form 23 submissions. They describe the research of computational scientists and clinical researchers working on brain lesions, and specifically glioma, multiple sclerosis, cerebral stroke, traumatic brain injuries, vestibular schwannoma, and white matter hyper-intensities of presumed vascular origin.